268 related articles for article (PubMed ID: 32132241)
21. Simian-Human Immunodeficiency Virus SHIV.C.CH505 Persistence in ART-Suppressed Infant Macaques Is Characterized by Elevated SHIV RNA in the Gut and a High Abundance of Intact SHIV DNA in Naive CD4
Obregon-Perko V; Bricker KM; Mensah G; Uddin F; Kumar MR; Fray EJ; Siliciano RF; Schoof N; Horner A; Mavigner M; Liang S; Vanderford T; Sass J; Chan C; Berendam SJ; Bar KJ; Shaw GM; Silvestri G; Fouda GG; Permar SR; Chahroudi A
J Virol; 2020 Dec; 95(2):. PubMed ID: 33087463
[TBL] [Abstract][Full Text] [Related]
22. Protection of rhesus monkeys against infection with minimally pathogenic simian-human immunodeficiency virus: correlations with neutralizing antibodies and cytotoxic T cells.
Quinnan GV; Yu XF; Lewis MG; Zhang PF; Sutter G; Silvera P; Dong M; Choudhary A; Sarkis PT; Bouma P; Zhang Z; Montefiori DC; Vancott TC; Broder CC
J Virol; 2005 Mar; 79(6):3358-69. PubMed ID: 15731230
[TBL] [Abstract][Full Text] [Related]
23. Standardized assessment of NAb responses elicited in rhesus monkeys immunized with single- or multi-clade HIV-1 envelope immunogens.
Seaman MS; Leblanc DF; Grandpre LE; Bartman MT; Montefiori DC; Letvin NL; Mascola JR
Virology; 2007 Oct; 367(1):175-86. PubMed ID: 17599382
[TBL] [Abstract][Full Text] [Related]
24. An env gene derived from a primary human immunodeficiency virus type 1 isolate confers high in vivo replicative capacity to a chimeric simian/human immunodeficiency virus in rhesus monkeys.
Reimann KA; Li JT; Voss G; Lekutis C; Tenner-Racz K; Racz P; Lin W; Montefiori DC; Lee-Parritz DE; Lu Y; Collman RG; Sodroski J; Letvin NL
J Virol; 1996 May; 70(5):3198-206. PubMed ID: 8627800
[TBL] [Abstract][Full Text] [Related]
25. Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeys.
Liang X; Casimiro DR; Schleif WA; Wang F; Davies ME; Zhang ZQ; Fu TM; Finnefrock AC; Handt L; Citron MP; Heidecker G; Tang A; Chen M; Wilson KA; Gabryelski L; McElhaugh M; Carella A; Moyer C; Huang L; Vitelli S; Patel D; Lin J; Emini EA; Shiver JW
J Virol; 2005 Oct; 79(19):12321-31. PubMed ID: 16160159
[TBL] [Abstract][Full Text] [Related]
26. Neutralization-sensitive R5-tropic simian-human immunodeficiency virus SHIV-2873Nip, which carries env isolated from an infant with a recent HIV clade C infection.
Siddappa NB; Song R; Kramer VG; Chenine AL; Velu V; Ong H; Rasmussen RA; Grisson RD; Wood C; Zhang H; Kankasa C; Amara RR; Else JG; Novembre FJ; Montefiori DC; Ruprecht RM
J Virol; 2009 Feb; 83(3):1422-32. PubMed ID: 19019970
[TBL] [Abstract][Full Text] [Related]
27. SHIV-C109p5 NHP induces rapid disease progression in elderly macaques with extensive GI viral replication.
Bose D; Deb Adhikary N; Xiao P; Rogers KA; Ferrell DE; Cheng-Mayer C; Chang TL; Villinger F
J Virol; 2024 Feb; 98(2):e0165223. PubMed ID: 38299866
[TBL] [Abstract][Full Text] [Related]
28. Rapid CD4+ T-lymphocyte depletion in rhesus monkeys infected with a simian-human immunodeficiency virus expressing the envelope glycoproteins of a primary dual-tropic Ethiopian Clade C HIV type 1 isolate.
Cayabyab M; Rohne D; Pollakis G; Mische C; Messele T; Abebe A; Etemad-Moghadam B; Yang P; Henson S; Axthelm M; Goudsmit J; Letvin NL; Sodroski J
AIDS Res Hum Retroviruses; 2004 Jan; 20(1):27-40. PubMed ID: 15000696
[TBL] [Abstract][Full Text] [Related]
29. Infection of rhesus macaques with a pool of simian immunodeficiency virus with the envelope genes from acute HIV-1 infections.
Krebs KC; Tian M; Asmal M; Ling B; Nelson K; Henry K; Gibson R; Li Y; Han W; Shattock RJ; Veazey RS; Letvin N; Arts EJ; Gao Y
AIDS Res Ther; 2016 Nov; 13(1):41. PubMed ID: 27906032
[TBL] [Abstract][Full Text] [Related]
30. Protection against a mixed SHIV challenge by a broadly neutralizing antibody cocktail.
Julg B; Liu PT; Wagh K; Fischer WM; Abbink P; Mercado NB; Whitney JB; Nkolola JP; McMahan K; Tartaglia LJ; Borducchi EN; Khatiwada S; Kamath M; LeSuer JA; Seaman MS; Schmidt SD; Mascola JR; Burton DR; Korber BT; Barouch DH
Sci Transl Med; 2017 Sep; 9(408):. PubMed ID: 28931655
[TBL] [Abstract][Full Text] [Related]
31. Human immunodeficiency virus type 1 envelope epitope-specific CD4(+) T lymphocytes in simian/human immunodeficiency virus-infected and vaccinated rhesus monkeys detected using a peptide-major histocompatibility complex class II tetramer.
Kuroda MJ; Schmitz JE; Lekutis C; Nickerson CE; Lifton MA; Franchini G; Harouse JM; Cheng-Mayer C; Letvin NL
J Virol; 2000 Sep; 74(18):8751-6. PubMed ID: 10954578
[TBL] [Abstract][Full Text] [Related]
32. Pathogenicity and mucosal transmissibility of the R5-tropic simian/human immunodeficiency virus SHIV(AD8) in rhesus macaques: implications for use in vaccine studies.
Gautam R; Nishimura Y; Lee WR; Donau O; Buckler-White A; Shingai M; Sadjadpour R; Schmidt SD; LaBranche CC; Keele BF; Montefiori D; Mascola JR; Martin MA
J Virol; 2012 Aug; 86(16):8516-26. PubMed ID: 22647691
[TBL] [Abstract][Full Text] [Related]
33. New SHIVs and Improved Design Strategy for Modeling HIV-1 Transmission, Immunopathogenesis, Prevention and Cure.
Li H; Wang S; Lee FH; Roark RS; Murphy AI; Smith J; Zhao C; Rando J; Chohan N; Ding Y; Kim E; Lindemuth E; Bar KJ; Pandrea I; Apetrei C; Keele BF; Lifson JD; Lewis MG; Denny TN; Haynes BF; Hahn BH; Shaw GM
J Virol; 2021 May; 95(11):. PubMed ID: 33658341
[TBL] [Abstract][Full Text] [Related]
34. Short- and long-term clinical outcomes in rhesus monkeys inoculated with a highly pathogenic chimeric simian/human immunodeficiency virus.
Endo Y; Igarashi T; Nishimura Y; Buckler C; Buckler-White A; Plishka R; Dimitrov DS; Martin MA
J Virol; 2000 Aug; 74(15):6935-45. PubMed ID: 10888632
[TBL] [Abstract][Full Text] [Related]
35. Vaccination of rhesus macaques with recombinant Mycobacterium bovis bacillus Calmette-Guérin Env V3 elicits neutralizing antibody-mediated protection against simian-human immunodeficiency virus with a homologous but not a heterologous V3 motif.
Someya K; Cecilia D; Ami Y; Nakasone T; Matsuo K; Burda S; Yamamoto H; Yoshino N; Kaizu M; Ando S; Okuda K; Zolla-Pazner S; Yamazaki S; Yamamoto N; Honda M
J Virol; 2005 Feb; 79(3):1452-62. PubMed ID: 15650171
[TBL] [Abstract][Full Text] [Related]
36. Human immunodeficiency virus type 1 envelope glycoprotein-specific cytotoxic T lymphocytes in simian-human immunodeficiency virus-infected rhesus monkeys.
Voss G; Li J; Manson K; Wyand M; Sodroski J; Letvin NL
Virology; 1995 Apr; 208(2):770-5. PubMed ID: 7747449
[TBL] [Abstract][Full Text] [Related]
37. Analytical Treatment Interruption after Short-Term Antiretroviral Therapy in a Postnatally Simian-Human Immunodeficiency Virus-Infected Infant Rhesus Macaque Model.
Goswami R; Nelson AN; Tu JJ; Dennis M; Feng L; Kumar A; Mangold J; Mangan RJ; Mattingly C; Curtis AD; Obregon-Perko V; Mavigner M; Pollara J; Shaw GM; Bar KJ; Chahroudi A; De Paris K; Chan C; Van Rompay KKA; Permar SR
mBio; 2019 Sep; 10(5):. PubMed ID: 31488511
[TBL] [Abstract][Full Text] [Related]
38. Advances in simian--human immunodeficiency viruses for nonhuman primate studies of HIV prevention and cure.
Bauer AM; Bar KJ
Curr Opin HIV AIDS; 2020 Sep; 15(5):275-281. PubMed ID: 32769631
[TBL] [Abstract][Full Text] [Related]
39. Central Nervous System Inflammation and Infection during Early, Nonaccelerated Simian-Human Immunodeficiency Virus Infection in Rhesus Macaques.
Hsu DC; Sunyakumthorn P; Wegner M; Schuetz A; Silsorn D; Estes JD; Deleage C; Tomusange K; Lakhashe SK; Ruprecht RM; Lombardini E; Im-Erbsin R; Kuncharin Y; Phuang-Ngern Y; Inthawong D; Chuenarom W; Burke R; Robb ML; Ndhlovu LC; Ananworanich J; Valcour V; O'Connell RJ; Spudich S; Michael NL; Vasan S
J Virol; 2018 Jun; 92(11):. PubMed ID: 29563297
[TBL] [Abstract][Full Text] [Related]
40. Viral burden and disease progression in rhesus monkeys infected with chimeric simian-human immunodeficiency viruses.
Reimann KA; Watson A; Dailey PJ; Lin W; Lord CI; Steenbeke TD; Parker RA; Axthelm MK; Karlsson GB
Virology; 1999 Mar; 256(1):15-21. PubMed ID: 10087222
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
